Cargando…
miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma
Neuroblastoma (NB) is the most common extracranial solid malignancy in children. Despite current aggressive treatment regimens, the prognosis for high‐risk NB patients remains poor, with the survival of less than 40%. Amplification/stabilization of MYCN oncogene, in NB is associated with a high risk...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944109/ https://www.ncbi.nlm.nih.gov/pubmed/31637848 http://dx.doi.org/10.1002/1878-0261.12588 |
_version_ | 1783484996866015232 |
---|---|
author | Chava, Srinivas Reynolds, C. Patrick Pathania, Anup S. Gorantla, Santhi Poluektova, Larisa Y. Coulter, Don W. Gupta, Subash C. Pandey, Manoj K. Challagundla, Kishore B. |
author_facet | Chava, Srinivas Reynolds, C. Patrick Pathania, Anup S. Gorantla, Santhi Poluektova, Larisa Y. Coulter, Don W. Gupta, Subash C. Pandey, Manoj K. Challagundla, Kishore B. |
author_sort | Chava, Srinivas |
collection | PubMed |
description | Neuroblastoma (NB) is the most common extracranial solid malignancy in children. Despite current aggressive treatment regimens, the prognosis for high‐risk NB patients remains poor, with the survival of less than 40%. Amplification/stabilization of MYCN oncogene, in NB is associated with a high risk of recurrence. Thus, there is an urgent need for novel therapeutics. The deregulated expression of microRNA (miR) is reported in NB; nonetheless, its effect on MYCN regulation is poorly understood. First, we identified that miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p (hereafter miR‐15a, miR‐15b or miR‐16) were down‐regulated in patient‐derived xenografts (PDX) with high MYCN expression. MiR targeting sequences on MYCN mRNA were predicted using online databases such as TargetScan and miR database. The R2 database, containing 105 NB patients, showed an inverse correlation between MYCN mRNA and deleted in lymphocytic leukemia (DLEU) 2, a host gene of miR‐15. Moreover, overexpression of miR‐15a, miR‐15b or miR‐16 significantly reduced the levels of MYCN mRNA and N‐Myc protein. Conversely, inhibiting miR dramatically enhanced MYCN mRNA and N‐Myc protein levels, as well as increasing mRNA half‐life in NB cells. By performing immunoprecipitation assays of argonaute‐2 (Ago2), a core component of the RNA‐induced silencing complex, we showed that miR‐15a, miR‐15b and miR‐16 interact with MYCN mRNA. Luciferase reporter assays showed that miR‐15a, miR‐15b and miR‐16 bind with 3’UTR of MYCN mRNA, resulting in MYCN suppression. Moreover, induced expression of miR‐15a, miR‐15b and miR‐16 significantly reduced the proliferation, migration, and invasion of NB cells. Finally, transplanting miR‐15a‐, miR‐15b‐ and miR‐16‐expressing NB cells into NSG mice repressed tumor formation and MYCN expression. These data suggest that miR‐15a, miR‐15b and miR‐16 exert a tumor‐suppressive function in NB by targeting MYCN. Therefore, these miRs could be considered as potential targets for NB treatment. |
format | Online Article Text |
id | pubmed-6944109 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69441092020-01-07 miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma Chava, Srinivas Reynolds, C. Patrick Pathania, Anup S. Gorantla, Santhi Poluektova, Larisa Y. Coulter, Don W. Gupta, Subash C. Pandey, Manoj K. Challagundla, Kishore B. Mol Oncol Research Articles Neuroblastoma (NB) is the most common extracranial solid malignancy in children. Despite current aggressive treatment regimens, the prognosis for high‐risk NB patients remains poor, with the survival of less than 40%. Amplification/stabilization of MYCN oncogene, in NB is associated with a high risk of recurrence. Thus, there is an urgent need for novel therapeutics. The deregulated expression of microRNA (miR) is reported in NB; nonetheless, its effect on MYCN regulation is poorly understood. First, we identified that miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p (hereafter miR‐15a, miR‐15b or miR‐16) were down‐regulated in patient‐derived xenografts (PDX) with high MYCN expression. MiR targeting sequences on MYCN mRNA were predicted using online databases such as TargetScan and miR database. The R2 database, containing 105 NB patients, showed an inverse correlation between MYCN mRNA and deleted in lymphocytic leukemia (DLEU) 2, a host gene of miR‐15. Moreover, overexpression of miR‐15a, miR‐15b or miR‐16 significantly reduced the levels of MYCN mRNA and N‐Myc protein. Conversely, inhibiting miR dramatically enhanced MYCN mRNA and N‐Myc protein levels, as well as increasing mRNA half‐life in NB cells. By performing immunoprecipitation assays of argonaute‐2 (Ago2), a core component of the RNA‐induced silencing complex, we showed that miR‐15a, miR‐15b and miR‐16 interact with MYCN mRNA. Luciferase reporter assays showed that miR‐15a, miR‐15b and miR‐16 bind with 3’UTR of MYCN mRNA, resulting in MYCN suppression. Moreover, induced expression of miR‐15a, miR‐15b and miR‐16 significantly reduced the proliferation, migration, and invasion of NB cells. Finally, transplanting miR‐15a‐, miR‐15b‐ and miR‐16‐expressing NB cells into NSG mice repressed tumor formation and MYCN expression. These data suggest that miR‐15a, miR‐15b and miR‐16 exert a tumor‐suppressive function in NB by targeting MYCN. Therefore, these miRs could be considered as potential targets for NB treatment. John Wiley and Sons Inc. 2019-11-29 2020-01 /pmc/articles/PMC6944109/ /pubmed/31637848 http://dx.doi.org/10.1002/1878-0261.12588 Text en © 2019 The Authors. Published by FEBS Press and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Chava, Srinivas Reynolds, C. Patrick Pathania, Anup S. Gorantla, Santhi Poluektova, Larisa Y. Coulter, Don W. Gupta, Subash C. Pandey, Manoj K. Challagundla, Kishore B. miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma |
title | miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma |
title_full | miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma |
title_fullStr | miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma |
title_full_unstemmed | miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma |
title_short | miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma |
title_sort | mir‐15a‐5p, mir‐15b‐5p, and mir‐16‐5p inhibit tumor progression by directly targeting mycn in neuroblastoma |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944109/ https://www.ncbi.nlm.nih.gov/pubmed/31637848 http://dx.doi.org/10.1002/1878-0261.12588 |
work_keys_str_mv | AT chavasrinivas mir15a5pmir15b5pandmir165pinhibittumorprogressionbydirectlytargetingmycninneuroblastoma AT reynoldscpatrick mir15a5pmir15b5pandmir165pinhibittumorprogressionbydirectlytargetingmycninneuroblastoma AT pathaniaanups mir15a5pmir15b5pandmir165pinhibittumorprogressionbydirectlytargetingmycninneuroblastoma AT gorantlasanthi mir15a5pmir15b5pandmir165pinhibittumorprogressionbydirectlytargetingmycninneuroblastoma AT poluektovalarisay mir15a5pmir15b5pandmir165pinhibittumorprogressionbydirectlytargetingmycninneuroblastoma AT coulterdonw mir15a5pmir15b5pandmir165pinhibittumorprogressionbydirectlytargetingmycninneuroblastoma AT guptasubashc mir15a5pmir15b5pandmir165pinhibittumorprogressionbydirectlytargetingmycninneuroblastoma AT pandeymanojk mir15a5pmir15b5pandmir165pinhibittumorprogressionbydirectlytargetingmycninneuroblastoma AT challagundlakishoreb mir15a5pmir15b5pandmir165pinhibittumorprogressionbydirectlytargetingmycninneuroblastoma |